You are here

BOUGHT

Yekra Player

Yekra is a revolutionary new distribution network for feature films.

Bought

 

The hidden story about vaccines, autism, drugs and food… Americas health has been BOUGHT. Your health, your family’s health. Now brought to you by Wall Street… “If you thought they hurt us with the banks, wait till you see what they’re doing to health care.” Vaccines. GMOs. Big Pharma. Three big, BIG, okay… HUGE topics in one film. Why? Why not 3 films, why put all this in one movie? Great question, 2 answers. 1st and most importantly: We need to band together. We need a mainstream film, not another radical movie that only interests the “already converted”. Over 5 million people supported Prop 37 in CA. Reportedly, over 2 million worldwide marched against Monsanto in a global protest. There...ane vaccine expansion, and our love affair with pharmaceuticals- it’s the same villain. It’s a risky story to tell, but would be a tragedy to passively consent to with silence. There is something horribly wrong with health care today. Huge money, billions and billions of dollars flowing into the same pockets. Meanwhile, MD’s aren’t being allowed to actually practice the art of medicine and anyone who questions vaccination safety, pharmaceuticals, factory farms, etc. is ridiculed and belittled. Meanwhile, the billions keep flowing, carried on a river of pain and anguish. Huge corporations funded by individual misery, one broken life at a time. Three huge stories, each worthy of multiple films, but each brought together by one staggering fact: it’s the same villain. These three story lines converge on Wall Street, in a tale of corruption, greed and shocking lack of conscience.

 

Fears over Africa meningitis epidemic

Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://news.bbc.co.uk/2/hi/health/2735783.stm

BBCi NEWS   SPORT   WEATHER   WORLD SERVICE   A-Z INDEX     

BBC News World Edition
 You are in: Health  
News Front Page
Africa
Americas
Asia-Pacific
Europe
Middle East
South Asia
UK
Business
Entertainment
Science/Nature
Technology
Health
Medical notes
-------------
Talking Point
-------------
Country Profiles
In Depth
-------------
Programmes
-------------
Cricket World Cup
BBC Sport
BBC Weather
SERVICES
-------------
EDITIONS
Friday, 7 February, 2003, 10:47 GMT
Fears over Africa meningitis epidemic
 
At least 3m doses of the vaccine will be shipped
 
Millions of people across Africa are to be vaccinated against a new killer strain of meningitis.

The World Health Organization has shipped an initial batch of 100,000 vaccines to Burkina Faso.

It follows fears of a possible epidemic across what health chiefs describe as Africa's meningitis belt, which stretches from Senegal to Ethiopia.

 

We have great hopes that this newly formulated vaccine will save many lives


 

Daniel Tarantola,
WHO
 

The vaccine will protect against the typical meningitis strains A and C and also the virulent W135 strain.

This strain of the disease has been found in sporadic cases on the continent last year.

It is believed to have claimed the lives of 1,743 people in Burkina Faso last year. So far this year, it has been linked to 244 deaths.

International programme

The WHO is planning to ship at least 3m doses of the vaccine over the coming months. It will be made available at reduced cost to governments in 21 countries.

The vaccine, was developed by GlaxoSmithKline, and funded for the most part by the Bill & Melinda Gates Foundation.

Until now, a vaccine covering the W135 strain cost between US $5 and US $50 per dose, which meant it was out of reach of many countries. The new vaccine will be available at US $1.50 per dose.

"It is possible that the W135 strain will not remain contained in Burkina Faso, but that it will spread to other countries in the meningitis belt, just like the A strain did 15 years ago," said Daniel Tarantola,WHO director of vaccines and biologicals.

"But we have great hopes that this newly formulated vaccine will save many lives and we are working on other vaccines that may, in the years to come, break the cycle of death and illness due to meningitis in this area."

Dr Gro Harlem Brundtland, WHO director general, praised the speed with which the vaccines have been developed and shipped.

"The record time in which we've come up with a vaccine and are making it available to those who need it is a testament to the fact that public-private partnerships can work for the betterment of health," she said.

Meningitis outbreaks occur almost every year during the dry season in the African meningitis belt.

The crucial epidemic period is usually in the first months of the year. In 2002 alone, there were at least 44,280 cases and 5,531 deaths reported to WHO's surveillance systems in the African region.

Medicins sans Frontiers welcomed the breakthrough but said the 3m doses would not be enough if the disease spread.

In a statement, it said: "If the W135 strain spreads to other countries in the African meningitis belt, the need could be as man as 20 to 50 million doses in the next five years."

 

See also:

 
09 Mar 99 | Medical notes
10 Apr 02 | Health
03 Jan 01 | Health
Internet links:

 


The BBC is not responsible for the content of external internet sites

 

Links to more Health stories are at the foot of the page.

 


 

 E-mail this story to a friend

Links to more Health stories
 


 

© BBC ^^ Back to top

 

News Front Page | Africa | Americas | Asia-Pacific | Europe | Middle East |
South Asia | UK | Business | Entertainment | Science/Nature |
Technology | Health | Talking Point | Country Profiles | In Depth |
Programmes

 


 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.